Search Results - "Falkson C"

Guideline for radiotherapy with curative intent in patients with early-stage medically inoperable non-small-cell lung cancer.

Authors: Falkson, C. B. Vella, E. T. Yu, E. et al.

Source: Current Oncology. Feb2017, Vol. 24 Issue 1, pe44-e49. 6p. 3 Charts.

Development of three African language translations of the FACT-G.

Authors: Mullin, V. Cella, D. Chang, C.-H. et al.

Source: Quality of Life Research. Feb2000, Vol. 9 Issue 2, p139-149. 11p.

Subjects: Questionnaires, Quality of life, Translations, Breast cancer treatment

Geographic Terms: South Africa

This result is not displayed to guests.
Login for full access.

Current treatment options for Malignant melanoma.

Authors: Cohen G Falkson C

Source: Drugs. Jun1998, Vol. 55 Issue 6, p791-799. 9p.

URL: 9593033

Therapeutic Revolution: The History of Medical Oncology From Early Days to the Creation of the Subspecialty.

Authors: Falkson, C. I.¹ cfalkson@uab.edu

Source: Current Oncology. Jun2015, Vol. 22 Issue 3, pe225-e226. 2p.

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030.

Authors: Parsons, H.A. Blewett, T. Chu, X. et al.

Source: Annals of Oncology. Oct2023, Vol. 34 Issue 10, p899-906. 8p.

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014.

Authors: Tsvetkova, E. Sud, S. Aucoin, N. et al.

Source: Current Oncology. Aug2015, Vol. 22 Issue 4, pe305-e315. 11p. 1 Chart.

Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of US Medicare beneficiaries, 1999-2006.

Authors: Sathiakumar, N. Delzell, E. Morrisey, M. A. et al.

Source: Prostate Cancer & Prostatic Diseases. 2011, Vol. 14 Issue 2, p177-183. 7p. 3 Charts, 1 Graph.

A phase II study of dexamethasone, ifosfamide, cisplatin and etoposide (DICE) as salvage chemotherapy for patients with relapsed and refractory lymphoma.

Authors: Biagi, J. J. Herbert, K. E. Smith, C. et al.

Source: Leukemia & Lymphoma. Feb2005, Vol. 46 Issue 2, p197-206. 10p.

TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker.

Authors: Mayer, E.L. Abramson, V. Jankowitz, R. et al.

Source: Annals of Oncology. Nov2020, Vol. 31 Issue 11, p1518-1525. 8p.

Imaging Technologies for High Dose Rate Brachytherapy for Cervical Cancer: A Systematic Review

Authors: D’Souza, D. Baldassarre, F. Morton, G. et al.

Source: Clinical Oncology. Sep2011, Vol. 23 Issue 7, p460-475. 16p.

Delivery of Brachytherapy for Cervical Cancer: Organisational and Technical Advice to Facilitate High-quality Care

Authors: Morton, G. Walker-Dilks, C. Baldassarre, F. et al.

Source: Clinical Oncology. Sep2010, Vol. 22 Issue 7, p605-614. 10p.

PD-118 High dose rate endobronchial brachytherapy (HDREB) in the palliation of patients with non-small cell lung cancer (NSCLC): A systematic review

Authors: Ung, Y. Yu, E. Falkson, C. et al.

Source: Lung Cancer (01695002). Jul2005 Supplement 2, Vol. 49, pS101-S102. 0p.

OC-0178: Demonstration of Catheter Insertion Using Electromagnetic Guidance in Breast Brachytherapy.

Authors: Brastianos, H. Vaughan, T. Lasso, A. et al.

Source: Radiotherapy & Oncology. May2017 Supplement 1, Vol. 123, pS91-S91. 1p.

Influence of bevacizumab on local-regional recurrence in triple negative breast cancer.

Authors: Prendergast, B. M. De Los Santos, J. F. Barrett, O. C. et al.

Source: Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p1617-1617. 1p.

A tri-modality imaging assessment algorithm to evaluate neoadjuvant therapy response in patients with operable breast cancer.

Authors: Umphrey, H. Bernreuter, W. Bland, K. et al.

Source: Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p829-829. 1p.

48 The importance of peer review in assuring quality of radiotherapy treatment planning: Results of a six-year experience

Authors: Brundage, M. Mackillop, W. Shelley, W. et al.

Source: Radiotherapy & Oncology. Sep2006, Vol. 80, pS15-S15. 1p.

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2025.

Authors: Ahmed A Mercier SL Ramjeesingh R et al.

Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2026 Apr 17; Vol. 33 (4). Date of Electronic Publication: 2026 Apr 17.

Publication Type: Journal Article; Consensus Statement

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE

Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes.

Authors: Lenz L Neff C Solimeno C et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Nov; Vol. 202 (1), pp. 191-201. Date of Electronic Publication: 2023 Aug 17.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor-Positive Breast Cancer: The BRACELET-01/PrE0113 Study.

Authors: Clark AS Zhao F Klein P et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Jul 01; Vol. 31 (13), pp. 2655-2662.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE